Last updated: July 25, 2023
Sponsor: Istituto Ortopedico Galeazzi
Overall Status: Active - Recruiting
Phase
N/A
Condition
N/ATreatment
sideremil vita cp
Clinical Study ID
NCT05806437
PBM(L4178)
Ages > 40 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Candidates for prosthetic surgery
- Patients of both sexes over 40 years of age
- Hemoglobin values <12 g% for females and 13 g% for males
- % transferrin saturation < 10%
- Willingness and ability to provide informed consent.
Exclusion
Exclusion Criteria:
- Patients with Mediterranean anemia
- Patients with coagulation disorders
- Patients who do not sign the consent form
- Pregnant or breastfeeding women (self-declaration)
- Minor aged
Study Design
Total Participants: 142
Treatment Group(s): 1
Primary Treatment: sideremil vita cp
Phase:
Study Start date:
June 01, 2023
Estimated Completion Date:
December 31, 2025
Study Description
Connect with a study center
IRCCS Istituto Ortopedico Galeazzi-Istituto Clinico San Siro
Milan,
ItalyActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.